Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the presentation of new one-year data from the CAHtalyst™ Adult study of CRENESSITY® (crinecerfont) showing that patients achieved lasting, ...

Neurocrine Biosciences has presented new one-year data from its Phase III CAHtalyst Adult study of Crenessity (crinecerfont) ...

British tennis player Tara Moore was banned for four years Tuesday after a court agreed with the International Tennis Integrity Agency that she should be suspended for using performance-enhancing ...

A trial tested the efficacy of corticosteroids in reducing interstitial fibrosis after kidney transplantation in low-risk patients.

There are all these drugs available, sitting in your local pharmacy, but they aren’t being used to treat all the conditions ...

Benadryl has been associated with worse school performance and, in one small study, impaired people’s ability to drive more ...

Adult and pediatric patients with classic congenital adrenal hyperplasia treated with CRENESSITY® (crinecerfont) achieved clin ...

Results from the Phase III CAHtalyst show that patients treated with Crenessity for classic congenital adrenal hyperplasia ...

A new study found that a few lifestyle factors can lower your risk of diverticulitis, which happens when pouches form in the ...

Kidney transplant recipients receiving the investigational cellular product MDR-101 achieved functional immune tolerance for ...

In Louisiana, people depend on Medicaid more than almost anywhere else in the country, with about one-third of the state ...

Of cats who test positive for heartworms, around 75–80% self-cure, while the others will succumb to the disease. Around 10% ...